Cargando…

SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022

SARS-CoV-2 transmission in Western Australia, Australia, was negligible until a wave of Omicron variant infections emerged in February 2022, when >90% of adults had been vaccinated. This unique pandemic experience enabled assessment of SARS-CoV-2 vaccine effectiveness (VE) without potential inter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bloomfield, Lauren E., Ngeh, Sera, Cadby, Gemma, Hutcheon, Kate, Effler, Paul V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202853/ https://www.ncbi.nlm.nih.gov/pubmed/37141626 http://dx.doi.org/10.3201/eid2906.230130

Ejemplares similares

Using data linkage to monitor COVID-19 vaccination: development of a vaccination linked data repository
por: Eitelhuber, Tom, et al.
Publicado: (2022)

Novaferon Effectively Inhibits Ancestral SARS-CoV-2 and Omicron Variant in Vitro, 2022
por: Ye, Fei, et al.
Publicado: (2022)

Occurrence of the Omicron variant of SARS-CoV-2 in northern Viet Nam in early 2022
por: Ung, Trang thi Hong, et al.
Publicado: (2022)

Persistence of the Omicron variant of SARS-CoV-2 in Australia: The impact of fluctuating social distancing
por: Chang, Sheryl L., et al.
Publicado: (2023)

Successful Control of an Onboard COVID-19 Outbreak Using the Cruise Ship as a Quarantine Facility, Western Australia, Australia
por: Codreanu, Tudor A., et al.
Publicado: (2021)

Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022
por: Bastard, Jonathan, et al.
Publicado: (2022)

Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
por: Aggarwal, Anupriya, et al.
Publicado: (2022)

Australia’s War against Rabbits: The Story of Rabbit Haemorrhagic Disease
por: Effler, Paul
Publicado: (2015)

Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
por: Lau, Jonathan J., et al.
Publicado: (2023)

Correlation of Binding and Neutralizing Antibodies against SARS-CoV-2 Omicron Variant in Infection-Naïve and Convalescent BNT162b2 Recipients
por: Fu, Jia, et al.
Publicado: (2022)

Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques
por: Chandrashekar, Abishek, et al.
Publicado: (2022)

Vaccine protection against the SARS-CoV-2 Omicron variant in macaques
por: Chandrashekar, Abishek, et al.
Publicado: (2022)

Household Secondary Attack Rates of SARS-CoV-2 Omicron Variant, South Korea, February 2022
por: Lim, Do Sang, et al.
Publicado: (2022)

Tracking the progressive spread of the SARS-CoV-2 Omicron variant in Italy, December 2021 to January 2022
por: Stefanelli, Paola, et al.
Publicado: (2022)

Effectiveness of COVID-19 Vaccination Against SARS-CoV-2 Omicron Variant Infection and Symptoms — China, December 2022–February 2023
por: Fu, Di, et al.
Publicado: (2023)

545. Remdesivir And Obeldesivir Retain Potent Activity Against SARS-CoV-2 Omicron Variants
por: Rodriguez, Lauren, et al.
Publicado: (2023)

Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January–March 2022
por: Mefsin, Yonatan M., et al.
Publicado: (2022)

Transmission dynamics of SARS-CoV-2 Omicron variant infections in Hangzhou, Zhejiang, China, January-February 2022
por: Xin, Hualei, et al.
Publicado: (2023)

Early Warning Surveillance for SARS-CoV-2 Omicron Variants, United Kingdom, November 2021–September 2022
por: Foulkes, Sarah, et al.
Publicado: (2023)

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
por: Altarawneh, Heba N., et al.
Publicado: (2022)

Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2
por: Lee, Richard Kuan-Lin, et al.
Publicado: (2022)

PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron
por: Su, Jingyi, et al.
Publicado: (2022)

Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatients
por: Lee, Hye Kyung, et al.
Publicado: (2022)

Limited cross-variant immune response from SARS-CoV-2 Omicron BA.2 in naïve but not previously infected outpatients
por: Lee, Hye Kyung, et al.
Publicado: (2022)

Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2
por: Yang, Yang, et al.
Publicado: (2022)

Vaccination with Omicron Inactivated Vaccine in Pre-vaccinated Mice Protects against SARS-CoV-2 Prototype and Omicron Variants
por: Zhang, Yuntao, et al.
Publicado: (2022)

Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants
por: Ong, Chon Phin, et al.
Publicado: (2023)

Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong
por: Xie, Ruopeng, et al.
Publicado: (2023)

Protective Effect of Inactivated COVID-19 Vaccines against Progression of SARS-CoV-2 Omicron and Delta Variant Infections to Pneumonia in Beijing, China, in 2022
por: Li, Juan, et al.
Publicado: (2022)

Effectiveness of COVID-19 vaccines against SARS-CoV-2 Omicron variants during two outbreaks from March to May 2022 in Quzhou, China
por: Yin, Zhiying, et al.
Publicado: (2023)

Travel-related Importation and Exportation Risks of SARS-CoV-2 Omicron Variant in 367 Prefectures (Cities) — China, 2022
por: Bai, Yuan, et al.
Publicado: (2022)

The Associated Factors of SARS-CoV-2 Reinfection by Omicron Variant — Guangdong Province, China, December 2022 to January 2023
por: Cai, Chunsheng, et al.
Publicado: (2023)

Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages — United States, January 2022–May 2023
por: Ma, Kevin C., et al.
Publicado: (2023)

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
por: Tseng, Hung Fu, et al.
Publicado: (2022)

Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees
por: Anichini, Gabriele, et al.
Publicado: (2022)

Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
por: Yang, Yang, et al.
Publicado: (2022)

Effect of booster vaccination against Delta and Omicron SARS-CoV-2 variants in Iceland
por: Norddahl, Gudmundur L., et al.
Publicado: (2022)

Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant
por: Zhang, Yuwei, et al.
Publicado: (2023)

Sensitivity of Rapid Antigen Tests Against SARS-CoV-2 Omicron and Delta Variants
por: Rao, Anuradha, et al.
Publicado: (2023)

Sensitivity of rapid antigen tests against SARS-CoV-2 Omicron and Delta variants
por: Rao, Anuradha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b1nk9fciuhsqtm8lt2gthed926